journal article·2022-10Open access

Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma

Zhihua Ou, Shitong Lin, Jiaying Qiu, Wencheng Ding, Peidi Ren, Dongsheng Chen, Jiaxuan Wang, Yihan Tong, Di Wu, Ao Chen, Yuan Deng, Mengnan Cheng, Ting Peng, Haorong Lu, Huanming Yang, Jian Wang, Xin Jin, Ding Ma, Xun Xu, Yanzhou Wang, Junhua Li, Peng Wu

Advanced Science· Volume 9· Issue 29

Abstract

Abstract The effective treatment of advanced cervical cancer remains challenging. Herein, single‐nucleus RNA sequencing (snRNA‐seq) and SpaTial enhanced resolution omics‐sequencing (Stereo‐seq) are used to investigate the immunological microenvironment of cervical squamous cell carcinoma (CSCC). The expression levels of most immune suppressive genes in the tumor and inflammation areas of CSCC are not significantly higher than those in the non‐cancer samples, except for LGALS9 and IDO1 . Stronger signals of CD56 + NK cells and immature dendritic cells are found in the hypermetabolic tumor areas, whereas more eosinophils, immature B cells, and Treg cells are found in the hypometabolic tumor areas. Moreover, a cluster of pro‐tumorigenic cancer‐associated myofibroblasts (myCAFs) are identified. The myCAFs may support the growth and metastasis of tumors by inhibiting lymphocyte infiltration and remodeling of the tumor extracellular matrix. Furthermore, these myCAFs are associated with poorer survival probability in patients with CSCC, predict resistance to immunotherapy, and might be present in a small fraction (< 30%) of patients with advanced cancer. Immunohistochemistry and multiplex immunofluorescence staining are conducted to validate the spatial distribution and potential function of myCAFs. Collectively, these findings enhance the understanding of the immunological microenvironment of CSCC and shed light on the treatment of advanced CSCC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · Cancer Immunotherapy and Biomarkers · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

BGI‐Zhenzhen Shenzhen 518083 China

Shenzhen Key Laboratory of Unknown Pathogen Identification BGI‐Shenzhen Shenzhen 518083 China

Cancer Biology Research Center (Key Laboratory of the Ministry of Education) Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

Department of Gynecologic Oncology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430000 China

College of Life Sciences University of Chinese Academy of Sciences Beijing 100049 China

College of Innovation and Experiment Northwest A&F University Yangling 712100 China

School of Basic Medicine Qingdao University Qingdao 266071 China

Department of Biology University of Copenhagen Copenhagen DK‐2200 Denmark

Department of Obstetrics and Gynecology Southwest Hospital Third Military Medical University Chongqing 400038 China

China National GeneBank BGI‐Shenzhen Shenzhen 518120 China

Guangdong Provincial Key Laboratory of Genome Read and Write Shenzhen 518120 China

James D. Watson Institute of Genome Sciences Hangzhou 310058 China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1016/S2214-109X(19)30482-610.1016/S2214-109X(19)30482-6 ↗
2. 10.3322/caac.2166010.3322/caac.21660 ↗
3. 10.1002/ijc.3015210.1002/ijc.30152 ↗
4. 10.1093/cid/ciab56110.1093/cid/ciab561 ↗
5. 10.1016/j.ygyno.2021.10.00710.1016/j.ygyno.2021.10.007 ↗
6. 10.1136/bmj.l120710.1136/bmj.l1207 ↗
7. 10.1016/S1470-2045(10)70230-810.1016/S1470-2045(10)70230-8 ↗
8. WHO A Global Strategy for elimination of cervical cancer – PAHO/WHO | Pan American Health Organization http://www.paho.org/en/topics/cervical‐cancer/global‐strategy‐elimination‐cervical‐cancer 2018 (accessed: October 2020).
9. 10.1634/theoncologist.2002-034210.1634/theoncologist.2002-0342 ↗
10. 10.1200/JCO.2017.75.998510.1200/JCO.2017.75.9985 ↗
11. 10.1016/S0140-6736(17)31607-010.1016/S0140-6736(17)31607-0 ↗
12. 10.1002/ijgo.1261110.1002/ijgo.12611 ↗
13. 10.1016/j.ygyno.2014.03.01310.1016/j.ygyno.2014.03.013 ↗
14. 10.1016/j.rpor.2018.05.00110.1016/j.rpor.2018.05.001 ↗
15. 10.1200/JCO.18.0126510.1200/JCO.18.01265 ↗
16. 10.1016/j.ctrv.2020.10208810.1016/j.ctrv.2020.102088 ↗
17. 10.1056/NEJMoa211243510.1056/NEJMoa2112435 ↗
18. 10.1200/JCO.2017.74.547110.1200/JCO.2017.74.5471 ↗
19. 10.1016/j.ygyno.2019.12.03410.1016/j.ygyno.2019.12.034 ↗
20. 10.1200/JCO.19.0073910.1200/JCO.19.00739 ↗
21. 10.1038/nrc.2016.7310.1038/nrc.2016.73 ↗
22. 10.1016/j.ccell.2021.09.00310.1016/j.ccell.2021.09.003 ↗
23. 10.1158/2159-8290.CD-20-148410.1158/2159-8290.CD-20-1484 ↗
24. 10.1016/j.ccell.2022.01.00410.1016/j.ccell.2022.01.004 ↗
25. 10.1016/j.ccell.2021.03.01210.1016/j.ccell.2021.03.012 ↗
26. 10.1038/s41467-019-14134-w10.1038/s41467-019-14134-w ↗
27. 10.1038/s41573-018-0004-110.1038/s41573-018-0004-1 ↗
28. 10.1016/j.ccell.2021.06.01710.1016/j.ccell.2021.06.017 ↗
29. 10.1038/s41467-018-07582-310.1038/s41467-018-07582-3 ↗
30. 10.1038/s41571-021-00546-510.1038/s41571-021-00546-5 ↗
31. 10.1016/j.omtn.2021.03.01710.1016/j.omtn.2021.03.017 ↗
32. 10.1016/j.ijrobp.2021.07.20910.1016/j.ijrobp.2021.07.209 ↗
33. 10.1371/journal.pone.020964810.1371/journal.pone.0209648 ↗
34. 10.1681/ASN.201809091210.1681/ASN.2018090912 ↗
35. 10.1016/j.ccell.2021.01.00610.1016/j.ccell.2021.01.006 ↗
36. 10.1038/s41586-022-04587-310.1038/s41586-022-04587-3 ↗
37. 10.1038/s41467-019-12917-910.1038/s41467-019-12917-9 ↗
38. 10.1016/j.cell.2022.04.00310.1016/j.cell.2022.04.003 ↗
39. 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I ↗
40. 10.1016/j.semcdb.2016.09.00510.1016/j.semcdb.2016.09.005 ↗
41. Borm L. E. · Neuroscience · 2022
42. 10.1126/science.aaf240310.1126/science.aaf2403 ↗
43. 10.1016/j.cell.2020.05.03910.1016/j.cell.2020.05.039 ↗
44. 10.1038/s41577-020-0296-310.1038/s41577-020-0296-3 ↗
45. 10.1038/nri340510.1038/nri3405 ↗
46. 10.1007/s00109-021-02116-910.1007/s00109-021-02116-9 ↗
47. 10.1038/cr.2016.15110.1038/cr.2016.151 ↗
48. 10.1158/1078-0432.CCR-19-028910.1158/1078-0432.CCR-19-0289 ↗
49. 10.1038/s41379-020-0550-z10.1038/s41379-020-0550-z ↗
50. 10.1038/s41419-020-03042-310.1038/s41419-020-03042-3 ↗
51. 10.1038/ni127110.1038/ni1271 ↗
52. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
53. 10.1152/physrev.00018.201910.1152/physrev.00018.2019 ↗
54. 10.3390/cancers1301013010.3390/cancers13010130 ↗
55. 10.1038/s41421-021-00271-410.1038/s41421-021-00271-4 ↗
56. 10.1038/s41467-020-18916-510.1038/s41467-020-18916-5 ↗
57. 10.1016/j.jhep.2020.05.03910.1016/j.jhep.2020.05.039 ↗
58. 10.3390/cancers1205130710.3390/cancers12051307 ↗
59. 10.1002/1878-0261.1283710.1002/1878-0261.12837 ↗
60. 10.1038/srep2058710.1038/srep20587 ↗
61. 10.1038/s41419-018-1116-610.1038/s41419-018-1116-6 ↗
62. 10.1016/S1535-6108(04)00081-910.1016/S1535-6108(04)00081-9 ↗
63. 10.1073/pnas.061137610410.1073/pnas.0611376104 ↗
64. 10.1002/path.123110.1002/path.1231 ↗
65. 10.1038/ng.381810.1038/ng.3818 ↗
66. 10.1002/1878-0261.1293710.1002/1878-0261.12937 ↗
67. 10.1136/gutjnl-2018-31764510.1136/gutjnl-2018-317645 ↗
68. 10.7150/thno.5507410.7150/thno.55074 ↗
69. 10.3390/cells910229710.3390/cells9102297 ↗
70. 10.1016/j.cell.2017.07.02910.1016/j.cell.2017.07.029 ↗
71. 10.1038/nrc238910.1038/nrc2389 ↗
72. 10.1186/s13045-021-01137-810.1186/s13045-021-01137-8 ↗
73. 10.1038/nrclinonc.2016.21710.1038/nrclinonc.2016.217 ↗
74. 10.15252/emmm.20170768910.15252/emmm.201707689 ↗
75. 10.1186/s12920-020-0682-510.1186/s12920-020-0682-5 ↗
76. 10.1002/jcp.3023610.1002/jcp.30236 ↗
77. 10.1158/0008-5472.CAN-20-027810.1158/0008-5472.CAN-20-0278 ↗
78. 10.1146/annurev.genet.41.110306.13014610.1146/annurev.genet.41.110306.130146 ↗
79. 10.1016/j.cell.2018.05.05210.1016/j.cell.2018.05.052 ↗
80. 10.1158/0008-5472.CAN-19-160110.1158/0008-5472.CAN-19-1601 ↗
81. 10.1186/s12964-020-00557-210.1186/s12964-020-00557-2 ↗
82. 10.1016/j.cell.2018.02.05210.1016/j.cell.2018.02.052 ↗
83. 10.1111/cas.1414810.1111/cas.14148 ↗
84. 10.1056/NEJMc171344410.1056/NEJMc1713444 ↗
85. 10.1056/NEJMoa150059610.1056/NEJMoa1500596 ↗
86. 10.1038/nrclinonc.2018.2910.1038/nrclinonc.2018.29 ↗
87. 10.3390/cancers1203069410.3390/cancers12030694 ↗
88. 10.1038/modpathol.2016.22110.1038/modpathol.2016.221 ↗
89. 10.1038/modpathol.2015.10810.1038/modpathol.2015.108 ↗
90. 10.1186/s13000-017-0631-610.1186/s13000-017-0631-6 ↗
91. 10.1001/jamaoncol.2017.377610.1001/jamaoncol.2017.3776 ↗
92. 10.1038/nm.431410.1038/nm.4314 ↗
93. 10.1093/glycob/cwn06210.1093/glycob/cwn062 ↗
94. 10.1016/j.immuni.2005.03.01310.1016/j.immuni.2005.03.013 ↗
95. 10.3390/cancers1206154710.3390/cancers12061547 ↗
96. 10.1038/s41571-019-0203-710.1038/s41571-019-0203-7 ↗
97. 10.1016/j.actbio.2020.09.00610.1016/j.actbio.2020.09.006 ↗
98. 10.1038/bjc.2013.76810.1038/bjc.2013.768 ↗
99. 10.1038/s41568-019-0238-110.1038/s41568-019-0238-1 ↗
100. 10.1093/bib/bbaa12710.1093/bib/bbaa127 ↗